Targeting NUPR1 by ZZW-115, alone and in combination with genotoxic agents, is an efficient strategy for PDAC treatment

Researcher: 
Velázquez Campoy, Adrián
Congress: 
52nd Meeting of the European Pancreatic Club combined with the International Association of Pancreatology
Participation type: 
Comunicación oral
Other authors: 
P. Santofimia-Castaño, W. Lan, M. Swayden, Y. Xia, Z. Zhou, S. Audebert, L. Camoin, C. Huang, L. Peng, V. Geli, A. Velazquez-Campoy, O. Abian, G. Lomberk, R. Urrutia, B. Rizzuti, P. Soubeyran, J. Neira, J. Iovanna
Year: 
2020
Location: 
Paris
Publication: 
P. Santofimia-Castaño, W. Lan, M. Swayden, Y. Xia, Z. Zhou, S. Audebert, L. Camoin, C. Huang, L. Peng, V. Geli, A. Velazquez-Campoy, O. Abian, G. Lomberk, R. Urrutia, B. Rizzuti, P. Soubeyran, J. Neira, J. Iovanna. Targeting NUPR1 by ZZW-115, alone and in combination with genotoxic agents, is an efficient strategy for PDAC treatment. En: 52nd Meeting of the European Pancreatic Club combined with the International Association of Pancreatology